Europe Human Insulin Market Size, Share & COVID-19 Impact Analysis, By Type (Analog Insulin, and Traditional Insulin), By Diabetes Type (Diabetes 1, and Diabetes 2), By Distribution Channel (Hospital Pharmacy, and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI107467

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 1.5% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	Type; Diabetes Type; Distribution Channel; and Country/Sub-Region
By Type	Analogue Insulin Long-acting Fast-acting Premix Traditional Human Insulin Long-acting + Intermediate Short-acting Fast-acting Premix
By Diabetes Type	Diabetes 1 Diabetes 2
By Distribution Channel	Hospital Pharmacies Retail & Online Pharmacies
By Country/Sub-Region	U.K. (By Diabetes Type) Germany (By Diabetes Type) France (By Diabetes Type) Italy (By Diabetes Type) Spain (By Diabetes Type) Scandinavia (By Diabetes Type) Rest of Europe (By Diabetes Type)